CDX2 expression is concordant between primary colorectal cancer lesions and corresponding liver metastases independent of chemotherapy: a single-center retrospective study in Japan

OBJECTIVE: Loss of caudal-type homeobox transcription factor 2 (CDX2) expression in colorectal cancers (CRCs) has recently been proposed as a promising predictive biomarker for not only prognosis but also response to chemotherapy. However, the relationship between alterations in CDX2 expression duri...

Descripción completa

Detalles Bibliográficos
Autores principales: Shigematsu, Yasuyuki, Inamura, Kentaro, Mise, Yoshihiro, Saiura, Akio, Rehnberg, Emil, Yamamoto, Noriko, Ishikawa, Yuichi, Takahashi, Shunji, Kanda, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908305/
https://www.ncbi.nlm.nih.gov/pubmed/29682204
http://dx.doi.org/10.18632/oncotarget.24842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908305/
https://www.ncbi.nlm.nih.gov/pubmed/29682204
http://dx.doi.org/10.18632/oncotarget.24842

Ejemplares similares